Antithrombotic/Anticoagulant Drugs: Technologies and Global Markets

  • ID: 3844007
  • Report
  • Region: Global
  • 156 Pages
  • BCC Research
15 % OFF
until Dec 31st 2018
1 of 6
The Global Market for Antithrombotic/Anticoagulant Drugs Should Reach $27.3 Billion by 2021 From $18.9 Billion in 2016 at a CAGR of 7.6% to 2021

FEATURED COMPANIES

  • Abbott Laboratories
  • Bayer AG
  • CSL Behring
  • F. Hoffmann-La Roche AG
  • Merck
  • Portola Pharmaceuticals
  • MORE

This Report Provides:

  • An overview of the global market for antithrombotic/anticoagulant drugs, which is changing due to factors such as an aging population, an increase in thrombotic events, and recent advances in pharmaceuticals
  • Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021
  • Breakdowns of the market size of anticoagulants by revenue at manufacturers' sales levels, including low molecular weight heparins and oral anticoagulants, as well as breakdowns of antiplatelets and thrombin inhibitors
  • Discussion of research and development of antithrombotic/anticoagulant treatments
  • Profiles of top leaders in each of the market segments along with companies that are novel or have specific interest to the field

This report is a comprehensive business tool designed to provide an in-depth look at antithrombotic/anticoagulant drugs for various cardiovascular applications. The geographic scope of the report is global, with a special emphasis on individual regions such as the United States, Europe, Asia-Pacific and the rest of world. The report describes the industry, its relationship to the healthcare industry and its participants and future trends.

Categories discussed in the report include:

  • Anticoagulants.
  • Antiplatelets.
  • Thrombin inhibitors.

All categories are discussed in detail, describing each segment, identifying current products on the market, measuring market size, identifying market drivers, forecasting for 2016 to 2021 and assessing the competitors their market shares.

Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Abbott Laboratories
  • Bayer AG
  • CSL Behring
  • F. Hoffmann-La Roche AG
  • Merck
  • Portola Pharmaceuticals
  • MORE

1: Introduction

  • Study Goals And Objectives
  • Reasons For Doing This Study
  • Scope Of The Study
  • Methodology And Information Sources

2: Executive Summary

3: Industry Overview

  • Major Developments
  • Sales Performance Of Major Drugs Projected Through 2020
  • Patent Analysis
  • Epidemic Of Cardiovascular Disease
  • Classification Of Cardiovascular Diseases
  • The Circulatory System
  • Conditions
  • Hemostasis (The Clotting Process)
  • Diseases Associated With Thromboembolism
  • Demographics

4: Anticoagulants

  • Overview
  • Products
  • Oral Anticoagulants (Vitamin K Antagonists)
  • Global Market Forecast
  • Competitive Analysis

5: Antiplatelets

  • Overview
  • Products
  • Global Market Forecast
  • Competitive Analysis

6: Thrombin Inhibitors

  • Overview
  • Products
  • Global Thrombin Inhibitor Market Forecast
  • Research And Development
  • Global Anticoagulant/Antithrombotic Market Forecast
  • Competitive Analysis

7: Company Profiles

  • Abbott Laboratories
  • Armetheon Inc.
  • Astrazeneca
  • Baxter International
  • Bayer AG
  • Biovascular Inc.
  • Boehringer Ingelheim Gmbh
  • Bristol-Myers Squibb Co.
  • CSL Behring
  • Daiichi Sankyo Co. Ltd.
  • Eli Lilly
  • Emisphere Technologies
  • F. Hoffmann-La Roche AG
  • Genentech
  • Glaxosmithkline
  • Johnson & Johnson
  • Ligand Pharmaceuticals Inc.
  • The Medicines Co.
  • Merck
  • Merrion Pharmaceuticals Ltd.
  • Microbix Biosystems Inc.
  • Novartis
  • ONO Pharmaceutical Co. Ltd.
  • Otsuka Pharmaceutical Co. Ltd.
  • Pfizer Inc.
  • Portola Pharmaceuticals
  • Revo Biologics Inc.
  • Sanofi
  • Santa Cruz Biotechnology Inc.
  • Servier Laboratories
  • Shire Pharmaceuticals
  • Sun Pharmaceuticals
  • TEVA Pharmaceuticals Ltd.

8: Appendix A: List Of Patents

  • Table 57 : List Of Patents On Antithrombotics And Anticoagulants, 2011-April 2016

9: Appendix B: Directory Of Companies Covered In This Report

List Of Tables

Summary Table : Global Market For Antithrombotic/Anticoagulant Drugs By Region, Through 2021
Table 1 : Praxbind (Idarucizumab) Drug Label
Table 2 : Global Market For Antithrombotic/Anticoagulant Drugs By Type, Through 2020
Table 3 : Epidemic Of Cardiovascular Diseases
Table 4 : Coronary Heart Disease Profile
Table 5 : Distribution Of Heart Disease By Race/Ethnicity, 2013
Table 6 : Acute Myocardial Infarction Disease Profile
Table 7 : Virchow's Triad: Three Main Factors In Predisposition To Pulmonary Embolism
Table 8 : Global Population By Selected Region, 2000-2050
Table 9 : Global Population Growth By Selected Region, 2000-2050
Table 10 : Lovenox Drug Label
Table 11 : Fragmin Drug Label
Table 12 : Innohep Drug Label
Table 13 : Orgaran Drug Label
Table 14 : Normiflo Drug Label
Table 15 : Embolex Drug Label
Table 16 : Fraxiparine Drug Label
Table 17 : Ariven/Arteven Drug Label
Table 18 : Global Market For Anticoagulant Drugs By Region, Through 2021
Table 19 : Global Market Shares Of Anticoagulant Drugs By Region, 2015
Table 20 : Global Market Shares Of Anticoagulant Drugs By Region, 2021
Table 21 : Global Market For Anticoagulant Drugs By Type, Through 2021
Table 22 : Global Market For Low Molecular Weight Heparin By Region, Through 2021
Table 23 : Global Market For Oral Anticoagulants (Vitamin K Antagonists) By Region, Through 2021
Table 24 : Global Market Shares Of Anticoagulant Drugs By Type, 2015
Table 25 : Global Market Shares Of Anticoagulant Drugs By Type, 2021
Table 26 : Global Market Shares Of Anticoagulant Drugs By Company, Competitive Analysis, 2014
Table 27 : Plavix Drug Label
Table 28 : Pletal Drug Label
Table 29 : Effient Drug Label
Table 30 : Brilinta Drug Label
Table 31 : Integrilin Drug Label
Table 32 : Aggrastat Drug Label
Table 33 : Reopro Drug Label
Table 34 : Global Market For Antiplatelet Drugs By Region, Through 2021
Table 35 : Global Market Shares Of Antiplatelet Drugs By Region, 2015
Table 36 : Global Market Shares Of Antiplatelet Drugs By Region, 2021
Table 37 : Global Market For Antiplatelet Drugs By Type, Through 2021
Table 38 : Global Market For Oral Antiplatelet Drugs By Region, Through 2021
Table 39 : Global Market For Iv Antiplatelet Drugs By Region, Through 2021
Table 40 : Global Market Shares Of Antiplatelet Drugs By Type, 2015
Table 41 : Global Market Shares Of Antiplatelet Drugs By Type, 2021
Table 42 : Global Market For Antiplatelet Drugs By Company, Competitive Analysis, 2014
Table 43 : Global Market For Thrombin Inhibitors By Region, Through 2021
Table 44 : Global Market Shares Of Sales Of Thrombin Inhibitors By Region, 2015
Table 45 : Global Market Shares Of Sales Of Thrombin Inhibitors By Region, 2021
Table 46 : Global Market For Thrombin Inhibitors By Type, Through 2021
Table 47 : Global Market Shares Of Thrombin Inhibitors By Type, 2015
Table 48 : Global Market Shares Of Sales Of Thrombin Inhibitors By Type, 2021
Table 49 : Global Market For Thrombin Inhibitor Drugs By Company, 2014
Table 50 : Global Market For Antithrombotic/Anticoagulant Drugs By Type, Through 2021
Table 51 : Global Market Shares Of Antithrombotic/Anticoagulant Drugs By Type, 2015
Table 52 : Global Market Shares Of Antithrombin/Anticoagulant Drugs By Type, 2021
Table 53 : Global Market For Antithrombotic/Anticoagulant Drugs By Region, Through 2021
Table 54 : Global Market Shares Of Antithrombotic/Anticoagulant Drugs By Region, 2015
Table 55 : Global Market Shares Of Antithrombotic/Anticoagulant Drugs By Region, 2021
Table 56 : Global Market For Antithrombin/Anticoagulant Drugs By Company, Competitive Analysis, 2014
Table 57 : List Of Patents On Antithrombotics And Anticoagulants, 2011-April 2016

List Of Figures

Summary Figure : Global Market For Antithrombotic/Anticoagulant Drugs By Region, 2015-2021
Figure 1 : Company Shares Of Patents On Antithrombotics And Anticoagulants, Jan. 2011 To April 2016
Figure 2 : Company Shares Of Patents On Anticoagulants, Jan. 2011 To April 2016
Figure 3 : Global Population Growth By Selected Region, 2000-2050
Figure 4 : Global Market For Anticoagulant Drugs By Region, 2015-2021
Figure 5 : Global Market Shares Of Anticoagulant Drugs By Region, 2015
Figure 6 : Global Market Shares Of Anticoagulant Drugs By Region, 2021
Figure 7 : Global Market For Oral Anticoagulants (Vitamin K Antagonists) By Region, 2015-2021
Figure 8 : Global Market Shares Of Anticoagulant Drugs By Type, 2015
Figure 9 : Global Market Shares Of Anticoagulant Drugs By Type, 2021
Figure 10 : Global Market Shares Of Anticoagulant Drugs By Company, Competitive Analysis, 2014
Figure 11 : Global Market For Antiplatelet Drugs By Region, 2015-2021
Figure 12 : Global Market Shares Of Antiplatelet Drugs By Region, 2015
Figure 13 : Global Market Shares Of Antiplatelet Drugs By Region, 2021
Figure 14 : Global Market For Antiplatelet Drugs By Type, 2015-2021
Figure 15 : Global Market Shares Of Antiplatelet Drugs By Type, 2015
Figure 16 : Global Market Shares Of Antiplatelet Drugs By Type, 2021
Figure 17 : Global Market For Antiplatelet Drugs By Company, Competitive Analysis, 2014
Figure 18 : Global Market For Thrombin Inhibitors By Region, 2015-2021
Figure 19 : Global Market Shares Of Sales Of Thrombin Inhibitors By Region, 2015
Figure 20 : Global Market Shares Of Sales Of Thrombin Inhibitors By Region, 2021
Figure 21 : Global Market For Thrombin Inhibitors By Type, 2015-2021
Figure 22 : Global Market Shares Of Thrombin Inhibitors By Type, 2015
Figure 23 : Global Market Shares Of Sales Of Thrombin Inhibitors By Type, 2021
Figure 24 : Global Market Shares Of Thrombin Inhibitor Drugs By Company, 2014
Figure 25 : Global Market For Antithrombotic/Anticoagulant Drugs By Type, 2015-2021
Figure 26 : Global Market Shares Of Antithrombin/Anticoagulant Drugs By Type, 2015
Figure 27 : Global Market Shares Of Antithrombotic/Anticoagulant Drugs By Type, 2021
Figure 28 : Global Market For Antithrombotic/Anticoagulant Drugs By Region, 2015-2021
Figure 29 : Global Market Shares Of Antithrombotic/Anticoagulant Drugs By Region, 2015
Figure 30 : Global Market Shares Of Antithrombotic/Anticoagulant Drugs By Region, 2021
Figure 31 : Global Market For Antithrombotic/Anticoagulant Drugs By Company, Competitive Analysis, 2014

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • Abbott Laboratories
  • Bayer AG
  • CSL Behring
  • F. Hoffmann-La Roche AG
  • Merck
  • Portola Pharmaceuticals
  • MORE

Analyst's Credentials:

Anuj Pathak is a market research analyst and a management graduate in computer management. He has an MBA, BSc from Devi Ahilya University (Indore, India). Anuj has strong knowledge and expertise in the healthcare domain, and he has worked on a variety of projects in various domains, including healthcare and information and communication technology (ICT). He has conducted extensive research on the pharmaceutical market, the medical device market, the biotechnology market, the surgical instrument market and other niche markets. Anuj also has experience in leading and training research teams.

Note: Product cover images may vary from those shown
5 of 6
  • Abbott Laboratories
  • Armetheon Inc.
  • Astrazeneca
  • Baxter International
  • Bayer AG
  • Biovascular Inc.
  • Boehringer Ingelheim Gmbh
  • Bristol-Myers Squibb Co.
  • CSL Behring
  • Daiichi Sankyo Co. Ltd.
  • Eli Lilly
  • Emisphere Technologies
  • F. Hoffmann-La Roche AG
  • Genentech
  • Glaxosmithkline
  • Johnson & Johnson
  • Ligand Pharmaceuticals Inc.
  • The Medicines Co.
  • Merck
  • Merrion Pharmaceuticals Ltd.
  • Microbix Biosystems Inc.
  • Novartis
  • ONO Pharmaceutical Co. Ltd.
  • Otsuka Pharmaceutical Co. Ltd.
  • Pfizer Inc.
  • Portola Pharmaceuticals
  • Revo Biologics Inc.
  • Sanofi
  • Santa Cruz Biotechnology Inc.
  • Servier Laboratories
  • Shire Pharmaceuticals
  • Sun Pharmaceuticals
  • TEVA Pharmaceuticals Ltd.
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll